168 related articles for article (PubMed ID: 24147084)
1. The identification and characterization of novel N-glycan-based biomarkers in gastric cancer.
Liu L; Yan B; Huang J; Gu Q; Wang L; Fang M; Jiao J; Yue X
PLoS One; 2013; 8(10):e77821. PubMed ID: 24147084
[TBL] [Abstract][Full Text] [Related]
2. Identification and assessment of new biomarkers for colorectal cancer with serum N-glycan profiling.
Zhao YP; Ruan CP; Wang H; Hu ZQ; Fang M; Gu X; Ji J; Zhao JY; Gao CF
Cancer; 2012 Feb; 118(3):639-50. PubMed ID: 21853445
[TBL] [Abstract][Full Text] [Related]
3. Decreased core-fucosylation contributes to malignancy in gastric cancer.
Zhao YP; Xu XY; Fang M; Wang H; You Q; Yi CH; Ji J; Gu X; Zhou PT; Cheng C; Gao CF
PLoS One; 2014; 9(4):e94536. PubMed ID: 24732908
[TBL] [Abstract][Full Text] [Related]
4. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
[TBL] [Abstract][Full Text] [Related]
5. Validation of N-glycan markers that improve the performance of CA19-9 in pancreatic cancer.
Zhao YP; Zhou PT; Ji WP; Wang H; Fang M; Wang MM; Yin YP; Jin G; Gao CF
Clin Exp Med; 2017 Feb; 17(1):9-18. PubMed ID: 26714469
[TBL] [Abstract][Full Text] [Related]
6. Identification of N- and O-linked glycans recognized by AAL in saliva of patients with atrophic gastritis and gastric cancer.
Shu J; Yu H; Du H; Zhang J; Zhang K; Li X; Xie H; Li Z
Cancer Biomark; 2018; 22(4):669-681. PubMed ID: 29865036
[TBL] [Abstract][Full Text] [Related]
7. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer.
Yin LK; Sun XQ; Mou DZ
Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051
[TBL] [Abstract][Full Text] [Related]
8. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
[TBL] [Abstract][Full Text] [Related]
9. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
10. Value of Combined Detection of Serum CEA, CA72-4, CA19-9, CA15-3 and CA12-5 in the Diagnosis of Gastric Cancer.
Chen C; Chen Q; Zhao Q; Liu M; Guo J
Ann Clin Lab Sci; 2017 May; 47(3):260-263. PubMed ID: 28667025
[TBL] [Abstract][Full Text] [Related]
11. Serum N-glycan profiling as a diagnostic biomarker for the identification and assessment of psoriasis.
Zou C; Huang C; Yan L; Li X; Xing M; Li B; Gao C; Wang H
J Clin Lab Anal; 2021 Apr; 35(4):e23711. PubMed ID: 33507566
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
Sun Z; Zhang N
World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
[TBL] [Abstract][Full Text] [Related]
13. N-glycan profiling alterations of serum and immunoglobulin G in immune thrombocytopenia.
Wang W; Xu X; Huang C; Gao C
J Clin Lab Anal; 2022 Feb; 36(2):e24201. PubMed ID: 34957618
[TBL] [Abstract][Full Text] [Related]
14. [Effect of huazhuo jiedu recipe on gastric juice compositions and tumor markers in patients with chronic atrophic gastritic precancerosis].
Li DG; Du YR; Guo M
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Apr; 31(4):496-9. PubMed ID: 21608221
[TBL] [Abstract][Full Text] [Related]
15. Serum N-glycans outperform CA19-9 in diagnosis of extrahepatic cholangiocarcinoma.
Wang M; Fang M; Zhu J; Feng H; Warner E; Yi C; Ji J; Gu X; Gao C
Electrophoresis; 2017 Nov; 38(21):2749-2756. PubMed ID: 28752594
[TBL] [Abstract][Full Text] [Related]
16. Serum N-Glycans: A New Diagnostic Biomarker for Light Chain Multiple Myeloma.
Chen J; Fang M; Zhao YP; Yi CH; Ji J; Cheng C; Wang MM; Gu X; Sun QS; Chen XL; Gao CF
PLoS One; 2015; 10(6):e0127022. PubMed ID: 26075387
[TBL] [Abstract][Full Text] [Related]
17. Serum glycan signatures of gastric cancer.
Ozcan S; Barkauskas DA; Renee Ruhaak L; Torres J; Cooke CL; An HJ; Hua S; Williams CC; Dimapasoc LM; Han Kim J; Camorlinga-Ponce M; Rocke D; Lebrilla CB; Solnick JV
Cancer Prev Res (Phila); 2014 Feb; 7(2):226-35. PubMed ID: 24327722
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran.
Nejadi-Kelarijani F; Roshandel G; Semnani S; Ahmadi A; Faghani B; Besharat S; Akhavan-Tabib A; Amiriani T
Asian Pac J Cancer Prev; 2014; 15(17):7433-6. PubMed ID: 25227854
[TBL] [Abstract][Full Text] [Related]
19. Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus.
Cao X; Shang QH; Chi XL; Zhang W; Xiao HM; Sun MM; Chen G; An Y; Lv CL; Wang L; Nan YM; Chen CY; Tan ZN; Liu XE; Zhuang H
World J Gastroenterol; 2020 Mar; 26(10):1067-1079. PubMed ID: 32205997
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer.
Pan YQ; Ruan YY; Peng JB; Han QY; Zhang X; Lin A; Yan WH
Hum Immunol; 2016 Apr; 77(4):317-24. PubMed ID: 26788811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
